HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoli Zheng Selected Research

3- O- xylopyranosylholosta- 7,9(11),22,24- tetraene- 3,17- diol

4/2009Development of nobiliside A loaded liposomal formulation using response surface methodology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoli Zheng Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 01/2014
8Esophageal Squamous Cell Carcinoma
05/2021 - 10/2014
8Pain (Aches)
09/2020 - 01/2019
6Inflammation (Inflammations)
10/2020 - 01/2018
6Hyperalgesia
09/2020 - 01/2019
5Renal Cell Carcinoma (Grawitz Tumor)
01/2019 - 01/2016
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2012
4Neoplasm Metastasis (Metastasis)
01/2019 - 01/2017
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2018
2Stomach Neoplasms (Stomach Cancer)
12/2021 - 01/2018
2Aplastic Anemia (Anemia, Hypoplastic)
10/2021 - 09/2013
2Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2021
2Diabetic Nephropathies (Diabetic Nephropathy)
05/2020 - 01/2019
2Carcinoma (Carcinomatosis)
01/2020 - 07/2018
2Carcinogenesis
01/2020 - 10/2012
2Ischemia
01/2020 - 01/2019
2Hypersensitivity (Allergy)
01/2020 - 11/2019
2Atherosclerosis
01/2020 - 10/2019
2Neuralgia (Stump Neuralgia)
11/2019 - 01/2019
2Leukemia
01/2019 - 01/2017
2Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 10/2014
2Headache (Headaches)
01/2018 - 02/2013
2Infections
01/2017 - 09/2002
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2015 - 09/2013
1Thrombotic Microangiopathies
08/2022
1Autistic Disorder (Autism)
01/2022
1Invasive Fungal Infections
01/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2021
1Hypoxia (Hypoxemia)
09/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Membranous Glomerulonephritis (Membranous Nephropathy)
11/2020
1Liver Neoplasms (Liver Cancer)
10/2020
1Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome)
09/2020

Drug/Important Bio-Agent (IBA)

9Long Noncoding RNAIBA
08/2020 - 01/2017
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
5prostaglandin-inositol cyclic phosphateIBA
09/2020 - 01/2019
4MicroRNAs (MicroRNA)IBA
12/2021 - 01/2019
4Therapeutic UsesIBA
01/2020 - 06/2014
4Pharmaceutical PreparationsIBA
01/2020 - 01/2016
3Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2016
3Messenger RNA (mRNA)IBA
01/2020 - 03/2012
3Histones (Histone)IBA
01/2020 - 01/2017
2CarcinogensIBA
05/2021 - 01/2020
2baicaleinIBA
01/2021 - 01/2021
2CurcuminIBA
10/2020 - 01/2020
2Analgesics (Analgesic Drugs)IBA
09/2020 - 11/2019
2InflammasomesIBA
05/2020 - 01/2020
2AcidsIBA
05/2020 - 11/2019
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2019
2Capsaicin (Zostrix)FDA Link
01/2020 - 11/2019
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 07/2019
2AntioxidantsIBA
01/2020 - 08/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2016
2Paclitaxel (Taxol)FDA LinkGeneric
11/2019 - 01/2019
2CytokinesIBA
01/2019 - 01/2018
2Liposomes (Liposome)IBA
01/2017 - 04/2009
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2017 - 01/2016
1cemiplimabIBA
01/2022
1camrelizumabIBA
01/2022
1sintilimabIBA
01/2022
1toripalimabIBA
01/2022
1AntibodiesIBA
01/2022
1NivolumabIBA
01/2022
1Arginine Vasopressin (Argipressin)IBA
01/2022
1tislelizumabIBA
01/2022
1Saline SolutionIBA
01/2022
1pembrolizumabIBA
01/2022
1durvalumabIBA
01/2022
1dostarlimabIBA
01/2022
1zimberelimabIBA
01/2022
1Vasopressins (Vasopressin)IBA
01/2022
1avelumabIBA
01/2022
1Voriconazole (Vfend)FDA LinkGeneric
01/2022
1LigandsIBA
01/2022
1atezolizumabIBA
01/2022
1Circular RNAIBA
12/2021
1Rituximab (Mabthera)FDA Link
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021
1Cytochrome P-450 CYP2C9IBA
05/2021
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2021
1Sirtuin 1IBA
01/2021
1intestinal peptide-proton cotransporterIBA
01/2021
13-methyladenineIBA
01/2021
1ubenimexIBA
01/2021
1pyruvate dehydrogenase kinase 4IBA
01/2021
1ThrombospondinsIBA
11/2020
1AutoantigensIBA
11/2020
1Fluorouracil (Carac)FDA LinkGeneric
10/2020
1InterleukinsIBA
10/2020
1salicylhydroxamic acid (SHAM)IBA
09/2020

Therapy/Procedure

11Therapeutics
01/2022 - 09/2002
7Radiotherapy
01/2022 - 01/2014
5Neoadjuvant Therapy
08/2020 - 10/2014
5Drug Therapy (Chemotherapy)
01/2020 - 01/2018
3Electroacupuncture
09/2020 - 11/2019
2Transplantation
08/2022 - 07/2018
2Hematopoietic Stem Cell Transplantation
01/2017 - 09/2013
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2021